Literature DB >> 27564470

Personal goals and expectations of OAB patients in the UK.

Angie Rantell1, Linda Cardozo1, Vik Khullar2.   

Abstract

INTRODUCTION: In clinical practice and in research patient-centred outcomes are often utilised to help improve communication between patients and clinicians and to help manage expectations from treatment. However, many of these goals are generic and do not adequately capture the details of day to day life that bother patients the most and that they hope will improve with therapy. This study aimed to understand what are the goals of patients with overactive bladder symptoms in the UK who were taking part in a clinical trial and to assess goal achievement.
METHODS: This was a qualitative analysis of the patients goals recorded using the Self-Assessment Goal Achievement (SAGA) Questionnaire during the UK study assessing flexible dose fesoterodine in adults (SAFINA) trial. Free text patient goals were completed at baseline and an assessment of achievement was performed at the end of treatment. Grounded theory was used to develop themes and sub themes.
RESULTS: Three hundred and thirty-one patients completed the trial and 1137 open ended goals were set. Six themes emerged from the data including, OAB, other LUTS and finishing the task in hand with multiple subthemes noted.
CONCLUSIONS: By assessing and understanding what is important to the patient, it may help to tailor patient care and treatment and improve patient satisfaction.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  overactive bladder; patient satisfaction; patient-centred outcomes; patients goals

Mesh:

Substances:

Year:  2016        PMID: 27564470     DOI: 10.1002/nau.23094

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  5 in total

1.  Vibegron for the Treatment of Patients with Dry and Wet Overactive Bladder: A Subgroup Analysis from the EMPOWUR Trial.

Authors:  David Staskin; Jeffrey Frankel; Susann Varano; Michael Kennelly; Diane K Newman; Matt T Rosenberg; Denise D Shortino; Rachael A Jankowich; Paul N Mudd
Journal:  Int J Clin Pract       Date:  2022-04-13       Impact factor: 3.149

Review 2.  Dealing with complex overactive bladder syndrome patient profiles with focus on fesoterodine: in or out of the EAU guidelines?

Authors:  John Heesakkers; Montserrat Espuña Pons; Philip Toozs Hobson; Emmanuel Chartier-Kastler
Journal:  Res Rep Urol       Date:  2017-10-31

3.  Expert Opinion on Three Clinical Cases with a Common Urgent Problem: Urge Urinary Incontinence.

Authors:  Andrea Tubaro; John Heesakkers; Jean Nicolas Cornu; Dudley Robinson
Journal:  Case Rep Urol       Date:  2018-10-16

Review 4.  Which drugs are best for overactive bladder? From patients' expectations to physicians' decisions.

Authors:  Ian Milsom; Adrian Wagg; Matthias Oelke; Christopher Chapple
Journal:  Int J Clin Pract       Date:  2020-12-11       Impact factor: 2.503

5.  Interpretation of the Meaningfulness of Symptom Reduction with Vibegron in Patients with Overactive Bladder: Analyses from EMPOWUR.

Authors:  Jeffrey Frankel; David Staskin; Susann Varano; Michael Kennelly; Diane K Newman; Matt T Rosenberg; Rachael A Jankowich; Denise Shortino; Paul N Mudd; Cynthia J Girman
Journal:  Adv Ther       Date:  2021-12-18       Impact factor: 3.845

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.